Project Grant HT94252410172
Award Date 4/1/24
Completion Date 3/31/28
Dollars Obligated $2.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32611, USA
Similar Awards
- The University of Florida Division of Sponsored Research was awarded a $745,408 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on April 1, 2024, will support research on the "Contribution of Repeat Associated Non-AUG (RAN) Proteins in Friedreich's and Other Hereditary Ataxias" over a 4-year period through March 31, 2028. This research aims to advance the understanding and...
- This $1,525,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports foundational studies at the University of Florida to understand the phenotypic, region-specific, and cell-specific dysregulation in the central nervous system of individuals with myotonic dystrophy. The 4-year award, effective May 15, 2024, will enable the university to conduct innovative research to advance the understanding of this neurological...
- The University of Florida (UF) received a $1,524,836 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on understanding and targeting common mechanisms of myotonic dystrophy types 1 and 2 using novel repeat expansion mouse models. The grant, which began on September 1, 2023 and will continue through August 31, 2027, supports UF's cutting-edge biomedical research efforts to transform healthcare for Service...
- The University of Florida was awarded a $5.796 million Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of September 1, 2023 through August 31, 2027. The grant will support the development of clinical candidates for the treatment of Myotonic Dystrophy at the University's location in Gainesville, Florida. As the prime awardee, the University will leverage its expertise in biomedical research to...
- The University of Florida was awarded a $305,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 2021 through March 2024 to develop novel therapies for dystonia. Through this funding, the University of Florida Division of Sponsored Research will conduct research into medical solutions for dystonia that can potentially transform healthcare for service members and the...
- Under a $1,525,000 Project Grant awarded by the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development), the University of Florida's Division of Sponsored Research will conduct research to "UNDERSTANDING AND TARGETING COMMON MECHANISMS OF MYOTONIC DYSTROPHY TYPES 1AND 2 USING NOVEL REPEAT EXPANSION MOUSE MODELS." This 4-year research project, commencing on Sep 1, 2023, will advance the understanding and treatment of myotonic dystrophy, a genetic disorder that...
- The University of Florida's Division of Sponsored Research received a $718,988 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 3-year project aims to test a novel oxygen release therapeutic for the preservation of spinal cord tissue resulting from spinal cord injury ischemia. Key products and services to be delivered include: Obtaining IACUC and institutional safety approvals, purchasing equipment and animals,...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $1,166,594 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded September 1, 2025, with completion targeted for August 31, 2029. The research project, titled "Early Cardiac Biomarkers of Inflammation and Remodeling in Duchenne Muscular Dystrophy (DMD)," focuses on identifying and characterizing early cardiac...
- This $953,125 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support research at the University of Florida to investigate MRI/MRS markers of skeletal muscle disease progression and vascular function in nonambulatory individuals with Duchenne muscular dystrophy. The research project will run from November 1, 2024 to October 31, 2027 and aims to advance understanding of neurodegenerative diseases...
- Federal Project Grant Award Summary The University of Florida's Division of Sponsored Research received a $482,708 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support research combining therapeutic acute intermittent hypoxia and respiratory-triggered diaphragm pacing to restore breathing function in chronic cervical spinal cord injury. The three-year project, which commenced September 30, 2025 and concludes...